NASDAQ:CTHR - Charles & Colvard, Ltd. Stock Price, Forecast & News

Charles & Colvard, Ltd. trades on the NASDAQ under the ticker symbol "CTHR."

Charles & Colvard, Ltd. (NASDAQ:CTHR) announced its quarterly earnings data on Thursday, November, 7th. The company reported $0.01 earnings per share (EPS) for the quarter. The company earned $7.61 million during the quarter, compared to analysts' expectations of $7.19 million. Charles & Colvard, Ltd. had a net margin of 7.14% and a return on equity of 5.77%. View Charles & Colvard, Ltd.'s Earnings History.

1 brokers have issued 12 month target prices for Charles & Colvard, Ltd.'s shares. Their forecasts range from $2.50 to $2.50. On average, they anticipate Charles & Colvard, Ltd.'s stock price to reach $2.50 in the next twelve months. This suggests a possible upside of 61.3% from the stock's current price. View Analyst Price Targets for Charles & Colvard, Ltd..

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Charles & Colvard, Ltd. in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Charles & Colvard, Ltd..

News headlines about CTHR stock have been trending negative this week, according to InfoTrie. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Charles & Colvard, Ltd. earned a coverage optimism score of -2.9 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Charles & Colvard, Ltd..

Charles & Colvard, Ltd. saw a drop in short interest during the month of December. As of December 31st, there was short interest totalling 117,300 shares, a drop of 20.3% from the December 15th total of 147,200 shares. Based on an average daily volume of 57,900 shares, the short-interest ratio is currently 2.0 days. Currently, 0.5% of the shares of the company are sold short. View Charles & Colvard, Ltd.'s Current Options Chain.

Some companies that are related to Charles & Colvard, Ltd. include Culp (CULP), Peak Resorts (SKIS), Bassett Furniture Industries (BSET), RYB Education (RYB), Flexsteel Industries (FLXS), Gaia (GAIA), Lifetime Brands (LCUT), DHX Media (DHXM), Dorel Industries (DIIBF), Phoenix New Media (FENG), Escalade (ESCA), LRAD (GNSS), LRAD (LRAD), Livexlive Media (LIVX) and Urban One (UONE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Charles & Colvard, Ltd. investors own include Corbus Pharmaceuticals (CRBP), Adamis Pharmaceuticals (ADMP), Allena Pharmaceuticals (ALNA), Biocept (BIOC), Catalyst Biosciences (CBIO), Flexion Therapeutics (FLXN), Veru (VERU), Devon Energy (DVN), Boston Beer (SAM) and Actinium Pharmaceuticals (ATNM).

Shares of CTHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CTHR stock can currently be purchased for approximately $1.55.

Charles & Colvard, Ltd. has a market capitalization of $44.92 million and generates $32.24 million in revenue each year. The company earns $2.27 million in net income (profit) each year or $0.10 on an earnings per share basis. Charles & Colvard, Ltd. employs 59 workers across the globe.View Additional Information About Charles & Colvard, Ltd..

The official website for Charles & Colvard, Ltd. is http://www.charlesandcolvard.com/.

Charles & Colvard, Ltd.'s mailing address is 170 SOUTHPORT DRIVE, MORRISVILLE NC, 27560. The company can be reached via phone at 919-468-0399 or via email at [email protected]